- Healthcare providers and prescribers across Minnesota now have the opportunity to leverage EHR-integrated prescription drug monitoring program (PDMP) data to make safer prescribing decisions.
The state PDMP recently went live with Appriss Health’s NarxCare platform and PMP AWARxE solution to enable providers to aggregate and analyze controlled substance data. The health IT solutions will also allow providers to access visual, graphic, and advanced analytics insights, as well as patient risk scores generated through machine learning.
These tools will equip healthcare providers with the knowledge to make better-informed clinical decisions for improved patient health outcomes. NarxCare will also give providers the tools and resources to connect patients at risk of substance use disorder (SUD) with treatment options when needed.
“The Minnesota Prescription Monitoring Program was implemented nine years ago to promote public health and welfare by detecting diversion, abuse and misuse of controlled substances,” said Minnesota Board of Pharmacy Executive Director Cody Wiberg, Pharm.D.
“We are proud of the recent progress we have made to make innovative technologies available to all prescribers and pharmacists statewide to help address the opioid epidemic,” Wiberg added.
Minnesota has been working steadily to help providers and pharmacists identify, manage, and prevent substance use disorder (SUD). In October 2018, Minnesota clinicians and prescribers queried the PDMP 695,715 times compared to 89,893 queries the same time last year. This represents a 673 percent increase year-over-year in PDMP queries.
“We remain wholly committed and unwavering in our support of the goal of the MNPMP – to assist in improving patient care and reducing the misuse of controlled substances for the benefit of all of the citizens of Minnesota,” said Wiberg.
The state also shared PDMP information with 38 states across the country through the PMP InterConnect hub.
“We are pleased to partner with Minnesota on the successful deployment of Appriss Health’s solutions that provide more information to clinicians, in a more meaningful way, to improve patient care,” said Appriss Health President Rob Cohen.
Appriss Health’s health IT solutions have helped to provide clinicians with insight into patient risk of overdose to curb the effects of the opioid epidemic.
“Across the nation today, 1.35 million prescribers and pharmacists utilize Appriss Health’s PDMP solutions to complete more than 15 million patient searches per month to help provide better patient outcomes,” said Cohen.
“We applaud the efforts of the Minnesota Board of Pharmacy to help providers more holistically determine if there are any controlled substance prescription use, misuse, or abuse concerns that would suggest further evaluation and/or discussion with their patients about treatment, if appropriate, and to assist in the reduction of their risk of addiction, overdose, and death,” he added.
Other states have also been implementing health IT solutions to enable EHR integration of PDMP data in an effort to curb the opioid epidemic.
In November, the North Carolina Department of Health and Human Services (NCDHHS) took steps to promote safer prescribing practices across the state.
The department leveraged Appriss Health’s PMP Gateway integration service to offer providers access to NarxCare and information from the state’s PDMP, the North Carolina Controlled Substance Reporting System (CSRS).
Ensuring prescribers have one-click access to state PDMP data helps to reduce administrative burden on providers by eliminating the need for prescribers to manually log into the PDMP’s website separately.
Reducing the administrative burden associated with EHR use is necessary for boosting the efficiency and effectiveness of PDMP use. The North Carolina Department of Health and Human Services is equipping providers with the tools to help clinicians more easily identify when there may be a problem with doctor shopping or opioid overuse.